CDK9 and colorectal cancer: Functionally, high expression of FGFR1 has been shown to be associated with increased proliferation and invasion of colorectal cancer cells [23]; MYO6 is known to be an oncogene in CRC [24], while CDK9 has been used as a potential target for the treatment of CRC [25].